{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:38:31Z","timestamp":1778909911160,"version":"3.51.4"},"reference-count":10,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>In recent years, several papers have been published on cardiovascular (CV) involvement, risk, management, and treatment in systemic inflammatory arthritis (SIA), including rheumatoid arthritis, (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA) [...]<\/jats:p>","DOI":"10.3390\/jcm12082779","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T03:19:54Z","timestamp":1681096794000},"page":"2779","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular Risk in Systemic Inflammatory Arthritis"],"prefix":"10.3390","volume":"12","author":[{"given":"Fabiola","family":"Atzeni","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-4696","authenticated-orcid":false,"given":"Alessandra","family":"Alciati","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, Villa S. Benedetto Menni, 22032 Albese con Cassano, Italy"},{"name":"Humanitas Clinical and Research Center, Rozzano, 20089 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/1744666X.2023.2170351","article-title":"Diagnosis and management of cardiovascular risk in rheumatoid arthritis: Main challenges and research agenda","volume":"19","author":"Atzeni","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_2","first-page":"e25633","article-title":"Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease","volume":"14","author":"Bhattad","year":"2022","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"970371","DOI":"10.3389\/fimmu.2022.970371","article-title":"The cardiometabolic conditions of psoriatic disease","volume":"13","author":"Toussirot","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2022.07.001","article-title":"\u201cCardiovascular, Obesity and Rheumatic Disease Study (CORDIS) Group\u201d of the Italian Society of Rheumatology (SIR). C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis","volume":"104","author":"Erre","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dijkshoorn, B., Raadsen, R., and Nurmohamed, M.T. (2022). Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102704"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","article-title":"Cardiovascular effects of approved drugs for rheumatoid arthritis","volume":"17","author":"Atzeni","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kokkonen, H., Johansson, L., Stenlund, H., and Rantap\u00e4\u00e4-Dahlqvist, S. (2022). Cardiovascular Risk Factors before Onset of Rheumatoid Arthritis Are Associated with Cardiovascular Events after Disease Onset: A Case-Control Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216535"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rojas-Gim\u00e9nez, M., L\u00f3pez-Medina, C., Ladehesa-Pineda, M.L., Puche-Larrubia, M.\u00c1., G\u00f3mez-Garc\u00eda, I., Calvo-Guti\u00e9rrez, J., Segu\u00ed-Azpilcueta, P., \u00c1balos-Aguilera, M.D.C., Ru\u00edz-Vilchez, D., and Escudero-Contreras, A. (2022). Subclinical Atherosclerosis Measure by Carotid Ultrasound and Inflammatory Activity in Patients with Rheumatoid Arthritis and Spondylarthritis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030662"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bonek, K., Kuca-Warmawin, E., Kormatka, A., Zielinska, A., Wislowaska, M., Kontny, E., and Gluszko, P. (2022). Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030766"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hokstad, I., Greco, D., Deyab, G., Fagerland, M.W., Agewall, S., Hjeltnes, G., Zimetti, F., Bernini, F., Ronda, N., and Hollan, I. (2022). Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies. J. Clin. Med., 11.","DOI":"10.3390\/jcm11247330"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2779\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:12:27Z","timestamp":1760123547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":10,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["jcm12082779"],"URL":"https:\/\/doi.org\/10.3390\/jcm12082779","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]}}}